1. 1013. Predicting RSV Efficacy for MK-1654 in Temperate and Tropical Climates using MBMA and Clinical Trial Simulation to Account for Seasonal Differences in RSV Force-of-Infection. (4th December 2021) Authors: Plock, Nele; Lommerse, Jos; Maas, Brian M; Chen, Jingxian; Bellanti, Francesco; Qin, Li; Witjes, Han; Pierrillas, Philippe; Railkar, Radha; Aliprantis, Antonios O; Vora, Kalpit A; Gao, Wei; Caro, Luzelena; Amy Cheung, S Y; Sachs, Jeffrey R Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A myoferlin gain‐of‐function variant associates with a new type of hereditary angioedema. Issue 11 (1st July 2020) Authors: Ariano, Anastasia; D'Apolito, Maria; Bova, Maria; Bellanti, Francesco; Loffredo, Stefania; D'Andrea, Giovanna; Intrieri, Mariano; Petraroli, Angelica; Maffione, Angela Bruna; Spadaro, Giuseppe; Santacroce, Rosa; Margaglione, Maurizio Journal: Allergy Issue: Volume 75:Issue 11(2020) Page Start: 2989 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients With Circulating Cryoglobulins. Issue 35 (September 2015) Authors: Bellanti, Francesco; Lauletta, Gianfranco; Villani, Rosanna; Lipsi, Maria Rosaria; Natalicchio, Maria Iole; Sansonno, Domenico; Vendemiale, Gianluigi; Serviddio, Gaetano Other Names: Agustin Castiella. section editor. Journal: Medicine Issue: Volume 94:Issue 35(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients With Circulating Cryoglobulins. Issue 35 (September 2015) Authors: Bellanti, Francesco; Lauletta, Gianfranco; Villani, Rosanna; Lipsi, Maria Rosaria; Natalicchio, Maria Iole; Sansonno, Domenico; Vendemiale, Gianluigi; Serviddio, Gaetano; Agustin, Castiella. Journal: Medicine Issue: Volume 94:Issue 35(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Eradication of HCV by direct antiviral agents restores mitochondrial function and energy homeostasis in peripheral blood mononuclear cells. Issue 12 (17th November 2022) Authors: Villani, Rosanna; Sangineto, Moris; Pontrelli, Paola; Bellanti, Francesco; Bukke, Vidyasagar N.; Moola, Archana; Gesualdo, Loreto; Vendemiale, Gianluigi; Grandaliano, Giuseppe; Stallone, Giovanni; Serviddio, Gaetano Journal: FASEB journal Issue: Volume 36:Issue 12(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Exposure‐response relationships for the efficacy and safety of filgotinib and its metabolite GS‐829845 in subjects with rheumatoid arthritis based on phase 2 and phase 3 studies. Issue 7 (14th February 2022) Authors: Meng, Amy; Anderson, Kacey; Nelson, Cara; Ni, Liyun; Chuang, Shu‐Min; Bellanti, Francesco; Chang, Peter; Comisar, Craig; Kearney, Brian P.; Bartok, Beatrix; Mathias, Anita Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 7(2022) Page Start: 3211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Fatal relapse of COVID-19 after recovery? A case report of an older Italian patient. Issue 1 (January 2021) Authors: Bellanti, Francesco; Lo Buglio, Aurelio; Custodero, Giacomo; Barbera, Lucia; Minafra, Graziano; Montrano, Marcella; De Biase, Fabio; Vendemiale, Gianluigi Journal: Journal of infection Issue: Volume 82:Issue 1(2021) Page Start: e49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Improved characterization of the pharmacokinetics of acalabrutinib and its pharmacologically active metabolite, ACP‐5862, in patients with B‐cell malignancies and in healthy subjects using a population pharmacokinetic approach. Issue 2 (21st August 2021) Authors: Edlund, Helena; Bellanti, Francesco; Liu, Huan; Vishwanathan, Karthick; Tomkinson, Helen; Ware, Joseph; Sharma, Shringi; Buil‐Bruna, Núria Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 2(2022) Page Start: 846 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Integration of PKPD relationships into benefit–risk analysis. (29th July 2015) Authors: Bellanti, Francesco; van Wijk, Rob C.; Danhof, Meindert; Della Pasqua, Oscar Journal: British journal of clinical pharmacology Issue: Volume 80:Number 5(2015:Nov.) Page Start: 979 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Mitochondrial dysfunction in nonalcoholic steatohepatitis. (April 2011) Authors: Serviddio, Gaetano; Bellanti, Francesco; Vendemiale, Gianluigi; Altomare, Emanuele Journal: Expert review of gastroenterology & hepatology Issue: Volume 5:Number 2(2011) Page Start: 233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗